Sign In
Buy FLXN
$25.10
-0.0069 (-0.0275%)
At Close: Jun 22, 2026
Flexion Therapeutics Announces Publication of New Abstracts Accepted at Osteoarthritis Research ...
12:00am, Friday, 01'st May 2020Flexion Therapeutics to Report First-Quarter 2020 Financial Results on May 7, 2020
08:30pm, Thursday, 30'th Apr 2020
Flexion Therapeutics, Inc. (FLXN) today announced that it will report its first-quarter 2020 financial results after the close of the U.S. financial markets on Thursday, May 7, 2020. The Company's co
Needham Maintains Buy on Flexion Therapeutics, Lowers Price Target to $30
12:36pm, Thursday, 30'th Apr 2020Flexion Therapeutics (NASDAQ:FLXN) PT Lowered to $20.00 at Raymond James
09:58am, Thursday, 30'th Apr 2020
Flexion Therapeutics (NASDAQ:FLXN) had its price objective reduced by Raymond James from $23.00 to $20.00 in a report published on Monday morning, AnalystRatings.com reports. Raymond James currently h
Needham Maintains a Buy Rating on Flexion Therapeutics (FLXN)
09:53am, Thursday, 30'th Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on Flexion Therapeutics (FLXN) today and set a price target of $30.00. The company's shares closed
Needham Maintains a Buy Rating on Flexion Therapeutics (FLXN)
09:53am, Thursday, 30'th Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on Flexion Therapeutics (FLXN – Research Report) today and set a price
Flexion Therapeutics Inc (NASDAQ:FLXN) Sees Significant Growth in Short Interest
09:04am, Wednesday, 29'th Apr 2020
Flexion Therapeutics Inc (NASDAQ:FLXN) was the recipient of a large growth in short interest in April. As of April 15th, there was short interest totalling 8,200,000 shares, a growth of 15.5% from the
$20.60 Million in Sales Expected for Flexion Therapeutics Inc (NASDAQ:FLXN) This Quarter
09:04am, Tuesday, 28'th Apr 2020
Analysts predict that Flexion Therapeutics Inc (NASDAQ:FLXN) will announce $20.60 million in sales for the current quarter, Zacks reports. Two analysts have made estimates for Flexion Therapeutics’
Flexion Therapeutics (NASDAQ:FLXN) Receives New Coverage from Analysts at Northland Securities
07:40am, Tuesday, 28'th Apr 2020
Investment analysts at Northland Securities began coverage on shares of Flexion Therapeutics (NASDAQ:FLXN) in a research note issued to investors on Monday, TipRanks reports. The brokerage set a “bu
ERBA Diagnostics (OTCMKTS:ERBA) & Flexion Therapeutics (OTCMKTS:FLXN) Head to Head Analysis
06:26am, Tuesday, 28'th Apr 2020
ERBA Diagnostics (OTCMKTS:ERBA) and Flexion Therapeutics (NASDAQ:FLXN) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their inst
Analysts Offer Insights on Healthcare Companies: Flexion Therapeutics (FLXN) and Dexcom (DXCM)
06:15pm, Monday, 27'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Flexion Therapeutics (FLXN) and Dexcom (DXCM) with bullish
Analysts Offer Insights on Healthcare Companies: Flexion Therapeutics (NASDAQ: FLXN) and Dexcom (NASDAQ: DXCM)
06:15pm, Monday, 27'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Flexion Therapeutics (
FLXN
–
Research Report
) and Dexcom (
DXCM
–
Research Report
) with bullish
Raymond James Maintains Strong Buy on Flexion Therapeutics, Lowers Price Target to $20
03:52pm, Monday, 27'th Apr 2020Northland Securities Initiates a Buy Rating on Flexion Therapeutics (FLXN)
01:22pm, Monday, 27'th Apr 2020
Northland Securities analyst Carl Byrnes initiated coverage with a Buy rating on Flexion Therapeutics (FLXN) today and set a price target of $35.00. The
Northland Securities Initiates a Buy Rating on Flexion Therapeutics (FLXN)
01:22pm, Monday, 27'th Apr 2020
Northland Securities analyst Carl Byrnes initiated coverage with a Buy rating on Flexion Therapeutics (FLXN – Research Report) today and
